Prosight Management, LP Oncorus, Inc. Transaction History

Prosight Management, LP

  • $372 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$5.03 - $11.63 $278,717 - $644,429
-55,411 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$9.29 - $14.27 $50,268 - $77,214
5,411 Added 10.82%
55,411 $518,000
Q2 2021

Aug 13, 2021
SELL
$13.3 - $17.3 $276,733 - $359,961
-20,807 Reduced 29.39%
50,000 $690,000
Q1 2021

May 14, 2021
BUY
$11.89 - $35.55 $841,895 - $2.52 Million
70,807 New
70,807 $986,000

About Oncorus, Inc.

ONCR Quotes by TradingView
  • Ticker ONCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,973,100
  • Description
  • Oncorus, Inc., a clinical-stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Phase I clinical trials for treating various canc...
More about ONCR
Track This Portfolio

Track Prosight Management, LP Portfolio

Follow Prosight Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosight Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Prosight Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email